Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting the forgotten transglycosylases.

Judy Halliday1, Declan McKeveney, Craig Muldoon

  • 1Alchemia Limited, 3 Hi-Tech Court, Eight Mile Plains, Brisbane Technology Park, Qld 4113, Australia.

Biochemical Pharmacology
|November 22, 2005
PubMed
Summary

Moenomycin inhibits bacterial peptidoglycan synthesis by targeting transglycosylase enzymes. Recent advances have renewed interest in these inhibitors for combating multidrug-resistant bacteria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SUMOylation of EphB4 enhances its stability in prostate cancer.

British journal of cancer·2026
Same author

Molecular characterisation of the Bacillus subtilis SpbK antiphage defence system.

Nature communications·2025
Same author

Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece.

Frontiers in chemistry·2024
Same author

Probing Disaccharide Binding to Triplatin as Models for Tumor Cell Heparan Sulfate (GAG) Interactions.

Inorganic chemistry·2023
Same author

A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections.

Science translational medicine·2022
Same author

In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile.

European journal of pharmacology·2020

Area of Science:

  • Microbiology
  • Natural Products Chemistry
  • Drug Discovery

Background:

  • Moenomycin, a natural product, inhibits peptidoglycan biosynthesis by targeting transglycosylase enzymes.
  • Despite early success, research on transglycosylase inhibitors stalled for decades due to process complexities.
  • The rise of multidrug-resistant bacteria has revitalized interest in targeting these enzymes.

Purpose of the Study:

  • To review recent developments in transglycosylase inhibitors over the past decade.
  • To highlight the renewed focus on targeting peptidoglycan biosynthesis for antibacterial therapies.
  • To discuss the potential of novel glycopeptides that inhibit transglycosylation.

Main Methods:

  • Literature review of research on transglycosylase inhibitors.

Related Experiment Videos

  • Analysis of recent advancements in understanding peptidoglycan biosynthesis.
  • Examination of new generation glycopeptides in clinical development.

    • Main Results:

    • Significant progress has been made in understanding the transglycosylation process.
    • New research tools have facilitated the study of transglycosylase enzymes.
    • Several novel transglycosylase inhibitors and glycopeptides are emerging.

    Conclusions:

    • Targeting transglycosylases represents a promising strategy against multidrug-resistant bacteria.
    • Advances in research have overcome previous limitations in studying these enzymes.
    • The development of transglycosylase inhibitors is gaining momentum.